1 2 3 4

is a comprehensive pharmaceutlical enterprise which focus on the r&d and production of microbial pharmaceuticals.the total asset of our company is rmb one billion yuan.thecompany covers an area of 300 acres.

   our main products are lincomycin hydrochlorlde api and its derivatives includs clindamycin hydrochloride and clindamycin phosphate, and other key products includes neomycin sulphate,moxidectin,framycetin sulphate .tenofovir disoproxil fumarate, nosihepitde premix.enramycin premix, etc.